Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 16:35
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 21°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Deep in Guideline]
¼ºÀΠõ½Ä 1´Ü°è Ä¡·á
¡®Àú¿ë·® ICS-Æ÷¸£¸ðÅ׷ѷΡ¯ ¼ö¿ë
ÀÓ¼¼Çü ±âÀÚ
2022-05-03 15:53
[Drug Review]
½ºÅ¸Æ¾ ODT ½Ã´ë ùÆ÷¹® ¿¾ú´Ù
ÀÌ»óµ· ±âÀÚ
2022-05-03 15:52
[Sub Story]
[1Â÷ÀÇ·á¿ë ±Ù°Å±â¹Ý ÀÌ»óÁöÁúÇ÷Áõ ÀÓ»óÁø·áÁöħ]
½ÉÇ÷°üÁúȯ ÃÊ°íÀ§Ç豺 LDL-C 70mg/dL ¹Ì¸¸ ±Ç°í
ÀÌ»óµ· ±âÀÚ
2022-05-03 15:51
[Sub Story]
[1Â÷ÀÇ·á¿ë ±Ù°Å±â¹Ý ´ç´¢º´ ÀÓ»óÁø·áÁöħ]
¡°Çѱ¹ÀÎ ¸ñÇ¥Ç÷´ç A1C 6.5% ¹Ì¸¸À¸·Î¡±
ÀÌ»óµ· ±âÀÚ
2022-05-03 15:50
[Cover Story]
1Â÷ÀÇ·á °¡À̵å¶óÀÎ ¸¸¼ºÁúȯ °í°µµ Ä¡·á ¼ö¿ëÇÒ±î?
ÀÌ»óµ· ±âÀÚ
2022-05-03 15:50
¶óÀÎ
[Sub Story]
[1Â÷ÀÇ·á¿ë ±Ù°Å±â¹Ý °íÇ÷¾Ð ÀÓ»óÁø·áÁöħ]
¡°½ÉÇ÷°üÁúȯ °íÀ§Ç豺 140mmHgº¸´Ù ³·°Ô öÀúÈ÷¡±
ÀÌ»óµ· ±âÀÚ
2022-05-03 15:44
[Interview]
¡°ACEI, »ç¸Á·ü ÁÙÀÌ´Â À¯ÀÏ RAS¾ïÁ¦Á¦¡±
ÀÌ»óµ· ±âÀÚ
2022-05-03 15:38
[Sub Story]
¡°Ã¶ÀúÇÑ Ç÷´çÁ¶Àý ½ÅÀåÁúȯ ¿¹¹æ¿¡ Àå±âÀûÀ¸·Î À¯È¿¡±
ÀÌ»óµ· ±âÀÚ
2022-05-03 15:30
[Sub Story]
¸®³ª±Û¸³Æ¾ ±¹³»¿¡¼ 10³â°£ ½×¾Æ¿Â ¾ÈÀü¼º
ÀÓ¼¼Çü ±âÀÚ
2022-05-03 15:13
[Conference Report]
¡°NODM ¾ÈÀü¼º È®ÀÎÇÑ ÇÇŸ¹Ù½ºÅ¸Æ¾,
¾Æ½Ã¾ÆÀο¡°Ô ÀûÇÕÇÑ ÁöÁú°ÇÏ Àü·«¡±
ÀÓ¼¼Çü ±âÀÚ
2022-05-03 14:47
¶óÀÎ
[Interview]
ÀÌ»óÁöÁúÇ÷Áõ °í·É¡¤½Å±ÔȯÀÚ Áõ°¡
ÀÌ»óµ· ±âÀÚ
2022-05-03 14:35
[Sub Story]
CKD Á¶±â¹ß°ß¡¤ÁÖ±âÀû ÃßÀû°üÂû °Á¶
ÀÓ¼¼Çü ±âÀÚ
2022-05-03 14:07
[Sub Story]
GERD ºÐ·ùº° Ä¡·áÀü·« Á¤¸®
ÀÓ¼¼Çü ±âÀÚ
2022-05-03 13:33
[Sub Story]
¾àÁ¦³»¼º ±Øº¹ÇÑ BÇü°£¿° ÀÓ»óÀû¿ë¹üÀ§ °³¼± ÇÊ¿ä
ÀÓ¼¼Çü ±âÀÚ
2022-05-03 13:30
[Primary Expert Opinion]
ÀÓ»óÇöÀåÀÇ ¿Ã¹Ù¸¥ Ç÷¾ÐÃøÁ¤°ú Ç÷¾Ðº¯µ¿¼º °ü¸®
THE MOST
2022-05-03 13:15
¶óÀÎ
[Conference Report]
¡°Àú¿ë·®½ºÅ¸Æ¾/¿¡Á¦Æ¼¹Ìºê º¹ÇÕÁ¦
CVD Àú¡¤ÁßÀ§Ç豺 °ü¸® ´ë¾È µÉ °Í¡±
ÀÌ»óµ· ±âÀÚ
2022-05-03 13:14
[Conference Report]
BSV, 336ÁÖ±îÁö È¿°ú¡¤¾ÈÀü¼º À¯Áö È®ÀÎ
ÀÓ¼¼Çü ±âÀÚ
2022-05-03 12:57
[Conference Report]
¡®¼Óµµ¹®Á¦¡¯ ±Øº¹ÇÑ PPI·Î GERD Àå±â°£ Á¶ÀýÇÑ´Ù
ÀÓ¼¼Çü ±âÀÚ
2022-05-03 11:35
[Conference Report]
Ú¸ ½ÉºÎÀü °¡À̵å¶óÀÎ °³Á¤
THE MOST
2022-05-03 11:16
[Conference Report]
MI ȯÀÚ °æÈ¹Ý °¨¼Ò¿¡ ½ºÅ¸Æ¾ ÆÄÆ®³Ê·Î PCSK9¾ïÁ¦Á¦
THE MOST
2022-05-03 11:11
-
1
2
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top